The global hormone sensitive prostate cancer market is poised for significant growth, with an estimated Compound Annual Growth Rate (CAGR) of 7.2% during the forecast period. According to recent market analysis, the sector generated revenue valued at USD 12.44 billion in 2023 and is projected to surpass USD 24.94 billion by 2033. Leading providers in …